04.26.24 -- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies

One of the most intriguing, high-stakes aspects of R&D is the realm of biosimilars. Explore the challenges of biosimilar production as well as aseptic processing considerations for biosimilars.

Dive into insightful discussions with PharmaLex expert Patrick Nieuwenhuizen as he highlights the key revisions and offers strategic insights on effectively implementing the updated Annex 1 guidelines.

Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

RTU containers are in demand, as they are supplied pre-washed and pre-sterilized and can be integrated directly into aseptic fill/finish lines. Find out about the latest RTU containment solutions.

The demand for high-concentration/subcutaneous drugs is on the rise. Explore opportunities for enhancing your biotech drug production platform.

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

The right comparator sourcing strategy is critical. Review what sponsors need to consider when selecting the right provider in order to source the needed commercial products.

Explore results from an experiment analyzing the USP monograph for cetirizine hydrochloride assay and organic impurities on two legacy HPLC systems and migrating them to the Alliance™ iS HPLC System.